ATE256682T1 - Sigma-2 rezeptoren als biomarkierer der tumorzellenproliferation - Google Patents

Sigma-2 rezeptoren als biomarkierer der tumorzellenproliferation

Info

Publication number
ATE256682T1
ATE256682T1 AT01928932T AT01928932T ATE256682T1 AT E256682 T1 ATE256682 T1 AT E256682T1 AT 01928932 T AT01928932 T AT 01928932T AT 01928932 T AT01928932 T AT 01928932T AT E256682 T1 ATE256682 T1 AT E256682T1
Authority
AT
Austria
Prior art keywords
sigma
biomarkers
receptors
cell proliferation
tumor cell
Prior art date
Application number
AT01928932T
Other languages
English (en)
Inventor
Robert H Mach
Kenneth T Wheeler
Original Assignee
Univ Wake Forest Health Sciences
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Wake Forest Health Sciences filed Critical Univ Wake Forest Health Sciences
Application granted granted Critical
Publication of ATE256682T1 publication Critical patent/ATE256682T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic Table
    • C07F13/005—Compounds without a metal-carbon linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/14—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing 9-azabicyclo [3.3.1] nonane ring systems, e.g. granatane, 2-aza-adamantane; Cyclic acetals thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT01928932T 2000-04-27 2001-04-27 Sigma-2 rezeptoren als biomarkierer der tumorzellenproliferation ATE256682T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20005200P 2000-04-27 2000-04-27
PCT/US2001/013583 WO2001080905A2 (en) 2000-04-27 2001-04-27 Sigma-2 receptors as biomarkers of tumor cell proliferation

Publications (1)

Publication Number Publication Date
ATE256682T1 true ATE256682T1 (de) 2004-01-15

Family

ID=22740117

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01928932T ATE256682T1 (de) 2000-04-27 2001-04-27 Sigma-2 rezeptoren als biomarkierer der tumorzellenproliferation

Country Status (7)

Country Link
US (1) US6669925B1 (de)
EP (1) EP1278745B1 (de)
AT (1) ATE256682T1 (de)
AU (1) AU2001255734A1 (de)
CA (1) CA2407520C (de)
DE (1) DE60101570T2 (de)
WO (1) WO2001080905A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1797106A1 (de) * 2004-09-07 2007-06-20 Triumf, operating as a joint venture by the Governors of the Universities of Alberta, Synthese von radioaktiv markierten zucker-metall-komplexen
IL298323B2 (en) 2020-05-20 2023-10-01 Univ Illinois A method for treating lysosomal storage disease using histatin peptides

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0235878A3 (de) 1986-01-16 1989-06-14 Beecham Group Plc Neue Verbindungen
DE3785507T2 (de) 1986-07-31 1993-07-29 Beecham Group Plc Azabicyclische verbindungen, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung.
US5223511A (en) * 1987-09-23 1993-06-29 Boehringer Ingelheim Italia S.P.A. Benzimidazoline-2-oxo-1-carboxylic acid compounds useful as 5-HT receptor antagonists
AU611976B2 (en) 1987-12-24 1991-06-27 John Wyeth & Brother Limited Aroyl urea and carbamic acid derivatives of azabicyclo compounds
DK443489D0 (da) 1989-09-08 1989-09-08 Ferrosan As Substituerede urinstofforbindelser, deres fremstilling og anvendelse
GB9121835D0 (en) 1991-10-15 1991-11-27 Smithkline Beecham Plc Pharmaceuticals
AU685225B2 (en) 1994-02-10 1998-01-15 Yamanouchi Pharmaceutical Co., Ltd. Novel carbamate derivative and medicinal composition containing the same
DE69739869D1 (de) * 1996-03-20 2010-06-17 Univ Wake Forest Health Sciences Sigma-2 rezeptoren als biomarkierer der tumorzellenproliferation

Also Published As

Publication number Publication date
DE60101570T2 (de) 2004-09-30
EP1278745A2 (de) 2003-01-29
WO2001080905A3 (en) 2002-05-30
AU2001255734A1 (en) 2001-11-07
DE60101570D1 (de) 2004-01-29
EP1278745B1 (de) 2003-12-17
WO2001080905A2 (en) 2001-11-01
US6669925B1 (en) 2003-12-30
CA2407520A1 (en) 2001-11-01
CA2407520C (en) 2010-02-02

Similar Documents

Publication Publication Date Title
ATE461217T1 (de) Glp-1-verbindungen
TR200000913T2 (tr) Tıbbi maddeler
DE60112974D1 (en) Carbolinderivate
DE60226499D1 (de) Verwendung von antikörpern gegen das muc18-antigen
DE60138927D1 (de) Menschlicher rezeptor für tumor necrosis factor
ATE438719T1 (de) Spezifischer marker für prostatakrebs
ATE364618T1 (de) Antikörper gegen das muc18-antigen
EA200301215A1 (ru) Лиганды рецепторов 5-ht и их применение
DK1558616T4 (da) Meso-substituerede porphyriner
AR010062A1 (es) Nuevos benzamidaldehidos y su utilizacion
DE60216233D1 (en) Carbolinderivate
UY3375Q (es) Esponja
ATE350662T1 (de) Markerproteine für prostatakrebs
ATE375978T1 (de) Benzoylsulfonamide als antitumor-mittel
ATE415961T1 (de) Therapeutische verwendung von mitgliedern der n,n-dicylcohexyl-2-hydroxy-7,7- dimethylbicycloä2.2.1ühept-1- ylmethanesulphonamide-familie
UY28344A1 (es) Nuevos compuestos
DE69942505D1 (de) Neuartige retinoide und deren verwendung
TR200200169T2 (tr) IL-18 inhibitörlerinin kullanımı.
DE60014064D1 (de) Einetenascin-c isoform als marker für neoplasmen
DE60122559D1 (de) Indolderivate als pde5-inhibitoren
BR0316544A (pt) Compostos calcilìticos
ATE256682T1 (de) Sigma-2 rezeptoren als biomarkierer der tumorzellenproliferation
ATE431742T1 (de) Modifizierte zytokine für krebs therapie
BRPI0408468A (pt) métodos para preparação e uso de 1(alfa),24(s)-diidroxivitamina d2
BRPI0415355A (pt) triarilimidazóis

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties
EEIH Change in the person of patent owner